Revvity Other Non-Current Liabilities 2010-2024 | RVTY
- Revvity other non-current liabilities for the quarter ending June 30, 2024 were $0.879B, a 7.87% decline year-over-year.
- Revvity other non-current liabilities for 2023 were $0.931B, a 16.07% decline from 2022.
- Revvity other non-current liabilities for 2022 were $1.109B, a 22.26% decline from 2021.
- Revvity other non-current liabilities for 2021 were $1.427B, a 84.21% increase from 2020.
Revvity Annual Other Non-Current Liabilities (Millions of US $) |
|
---|---|
2023 | $931 |
2022 | $1,109 |
2021 | $1,427 |
2020 | $775 |
2019 | $751 |
2018 | $742 |
2017 | $849 |
2016 | $460 |
2015 | $465 |
2014 | $443 |
2013 | $417 |
2012 | $442 |
2011 | $470 |
2010 | $344 |
2009 | $364 |
Revvity Quarterly Other Non-Current Liabilities (Millions of US $) |
|
---|---|
2024-06-30 | $879 |
2024-03-31 | $920 |
2023-12-31 | $931 |
2023-09-30 | $993 |
2023-06-30 | $954 |
2023-03-31 | $1,010 |
2022-12-31 | $1,109 |
2022-09-30 | $1,232 |
2022-06-30 | $1,311 |
2022-03-31 | $1,355 |
2021-12-31 | $1,427 |
2021-09-30 | $1,512 |
2021-06-30 | $839 |
2021-03-31 | $828 |
2020-12-31 | $775 |
2020-09-30 | $721 |
2020-06-30 | $703 |
2020-03-31 | $704 |
2019-12-31 | $751 |
2019-09-30 | $690 |
2019-06-30 | $717 |
2019-03-31 | $689 |
2018-12-31 | $742 |
2018-09-30 | $721 |
2018-06-30 | $744 |
2018-03-31 | $785 |
2017-12-31 | $849 |
2017-09-30 | $496 |
2017-06-30 | $488 |
2017-03-31 | $463 |
2016-12-31 | $460 |
2016-09-30 | $489 |
2016-06-30 | $488 |
2016-03-31 | $487 |
2015-12-31 | $465 |
2015-09-30 | $396 |
2015-06-30 | $401 |
2015-03-31 | $403 |
2014-12-31 | $443 |
2014-09-30 | $398 |
2014-06-30 | $408 |
2014-03-31 | $409 |
2013-12-31 | $417 |
2013-09-30 | $409 |
2013-06-30 | $386 |
2013-03-31 | $381 |
2012-12-31 | $442 |
2012-09-30 | $434 |
2012-06-30 | $417 |
2012-03-31 | $445 |
2011-12-31 | $470 |
2011-09-30 | $431 |
2011-06-30 | $409 |
2011-03-31 | $373 |
2010-12-31 | $344 |
2010-09-30 | $344 |
2010-06-30 | $368 |
2010-03-31 | $369 |
2009-12-31 | $364 |
2009-09-30 | $364 |
2009-06-30 | $347 |
2009-03-31 | $330 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $14.682B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $98.658B | 12.24 |
Cencora (COR) | United States | $49.082B | 18.10 |
DiDi Global (DIDIY) | China | $23.427B | 0.00 |
ICON (ICLR) | Ireland | $17.504B | 15.59 |
Natera (NTRA) | United States | $16.570B | 0.00 |
Viatris (VTRS) | United States | $15.624B | 4.81 |
Avantor (AVTR) | United States | $15.178B | 22.75 |
BioMerieux (BMXMF) | France | $13.087B | 0.00 |
CochLear (CHEOY) | Australia | $12.998B | 0.00 |
Solventum (SOLV) | United States | $12.357B | 0.00 |
Doximity (DOCS) | United States | $11.372B | 67.31 |
Medpace Holdings (MEDP) | United States | $11.301B | 31.84 |
Charles River Laboratories (CRL) | United States | $11.285B | 21.81 |
HealthEquity (HQY) | United States | $8.756B | 47.52 |
Sonic Healthcare (SKHHY) | Australia | $8.590B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $7.202B | 33.53 |
Life Times (LTH) | United States | $5.139B | 34.01 |
Sotera Health (SHC) | United States | $4.509B | 24.12 |
Organon (OGN) | United States | $4.144B | 4.18 |
Surgery Partners (SGRY) | United States | $3.996B | 44.27 |
BrightSpring Health Services (BTSG) | United States | $3.489B | 74.22 |
PACS (PACS) | United States | $3.347B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.580B | 0.00 |
Concentras Parent (CON) | United States | $2.505B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.471B | 0.00 |
Premier (PINC) | United States | $2.314B | 11.55 |
Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.016B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
Teladoc Health (TDOC) | United States | $1.689B | 0.00 |
Progyny (PGNY) | United States | $1.540B | 27.08 |
Pediatrix Medical (MD) | United States | $1.371B | 13.41 |
Establishment Labs Holdings (ESTA) | $1.266B | 0.00 | |
CareDx (CDNA) | United States | $1.252B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $1.058B | 7.16 |
Embecta (EMBC) | United States | $0.910B | 6.07 |
Agilon Health (AGL) | United States | $0.890B | 0.00 |
InnovAge Holding (INNV) | United States | $0.809B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
SBC Medicals (SBC) | United States | $0.723B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
DocGo (DCGO) | United States | $0.411B | 15.46 |
Enhabit (EHAB) | United States | $0.403B | 34.83 |
COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
LifeMD (LFMD) | United States | $0.308B | 0.00 |
Sera Prognostics (SERA) | United States | $0.248B | 0.00 |
ModivCare (MODV) | United States | $0.231B | 12.54 |
Beauty Health (SKIN) | United States | $0.218B | 0.00 |
Biodesix (BDSX) | United States | $0.205B | 0.00 |
Nutex Health (NUTX) | United States | $0.152B | 0.00 |
MultiPlan (MPLN) | United States | $0.137B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
So-Young (SY) | China | $0.088B | 21.28 |
Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
OncoCyte (OCX) | United States | $0.049B | 0.00 |
NeueHealth (NEUE) | United States | $0.042B | 1.10 |
Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
Oncology Institute (TOI) | United States | $0.020B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
XWELL (XWEL) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
KindlyMD (KDLY) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |